Tenax Therapeutics (TENX) Equity Average (2011 - 2026)
Tenax Therapeutics recorded quarterly Equity Average of $105.9 million in Q1 2026, up 9.56% quarter-over-quarter from $96.6 million in Q4 2025, and up 5.21% year-over-year from $100.6 million in Q1 2025.
Tenax Therapeutics' Equity Average history runs 14 years deep, the most recent figure standing at $105.9 million for Q1 2026.
- In Q1 2026, Equity Average rose 5.21% year-over-year to $105.9 million; the TTM figure through Mar 2026 stood at $105.9 million (up 5.21% YoY), while the FY2025 annual figure was $94.5 million, up 88.89% from the prior year.
- Equity Average came in at $105.9 million for Q1 2026 at Tenax Therapeutics, up from $96.6 million in the prior quarter.
- In the past five years, Equity Average ranged from a high of $106.3 million in Q2 2025 to a low of $2.7 million in Q4 2022.
- A 5-year average of $43.3 million and a median of $12.3 million in 2023 frame the typical range for Equity Average.
- Across the five-year window, Equity Average slumped 52.57% in 2022 and jumped 897.99% in 2025, its largest moves.
- Tenax Therapeutics' Equity Average stood at $2.7 million in 2022, then soared by 255.89% to $9.7 million in 2023, then jumped by 876.11% to $94.6 million in 2024, then climbed by 2.15% to $96.6 million in 2025, then rose by 9.56% to $105.9 million in 2026.
- According to Business Quant data, Equity Average over the past three periods registered $105.9 million, $96.6 million, and $99.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.76 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 21.35 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 19.01 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 31.34 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 932.28 Mn |
| 10 | Tenax Therapeutics | 542.72 Mn | 542.72 Mn | - | 105.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 105.88 Mn |
| Dec 31, 2025 | 96.64 Mn |
| Sep 30, 2025 | 99.77 Mn |
| Jun 30, 2025 | 106.31 Mn |
| Mar 31, 2025 | 100.64 Mn |
| Dec 31, 2024 | 94.61 Mn |
| Sep 30, 2024 | 53.05 Mn |
| Jun 30, 2024 | 10.65 Mn |
| Mar 31, 2024 | 10.26 Mn |
| Dec 31, 2023 | 9.69 Mn |
| Sep 30, 2023 | 12.25 Mn |
| Jun 30, 2023 | 13.75 Mn |
| Mar 31, 2023 | 7.89 Mn |
| Dec 31, 2022 | 2.72 Mn |
| Sep 30, 2022 | 5.37 Mn |
| Jun 30, 2022 | 4.20 Mn |
| Mar 31, 2022 | 2.93 Mn |
| Dec 31, 2021 | 5.74 Mn |
| Sep 30, 2021 | 4.35 Mn |
| Jun 30, 2021 | 2.28 Mn |
| Mar 31, 2021 | 3.86 Mn |
| Dec 31, 2020 | 6.01 Mn |
| Sep 30, 2020 | 5.22 Mn |
| Jun 30, 2020 | 3.22 Mn |
| Mar 31, 2020 | 3.60 Mn |
| Dec 31, 2019 | 121.84 Mn |
| Sep 30, 2019 | 119.96 Mn |
| Jun 30, 2019 | 930.00 |
| Mar 31, 2019 | 5.89 Mn |
| Dec 31, 2018 | 8.35 Mn |
| Sep 30, 2018 | 5.57 Mn |
| Jun 30, 2018 | 7.11 Mn |
| Mar 31, 2018 | 8.43 Mn |
| Dec 31, 2017 | 9.52 Mn |
| Sep 30, 2017 | 10.72 Mn |
| Jun 30, 2017 | 12.69 Mn |
| Mar 31, 2017 | 15.63 Mn |
| Dec 31, 2016 | 31.92 Mn |
| Sep 30, 2016 | 48.79 Mn |
| Apr 30, 2013 | -1.69 Mn |
| Jan 31, 2013 | -829,302.00 |
| Oct 31, 2012 | -348,165.00 |
| Jul 31, 2012 | -492,172.50 |
| Apr 30, 2012 | -608,755.00 |
| Jan 31, 2012 | -2.30 Mn |
| Oct 31, 2011 | -2.67 Mn |
| Jul 31, 2011 | -2.67 Mn |